GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)

Clinical trial NCT05819658 · COMPLETED

Trial details

NCT number: NCT05819658
Sponsor: GemVax & Kael
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy

Start date: 2023-06-14
Primary completion: 2024-10-11
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.